Banner

News

Article

Physician input needed: Do you prescribe semaglutide or other GLP-1RAs?

Are your patients asking about Ozempic and other GLP-1RAs? Are you prescribing it? Take our quick survey.

semaglutide | © Peter Hansen - stock.adobe.com

© Peter Hansen - stock.adobe.com

Take our quick survey

One of the hottest topics in medicine right now is the potentially revolutionary use of Glucagon-like peptide-1 receptor agonist (GLP-1RAs) drugs to manage overweight/obesity. These medicines are popularly known to patients by brand names like Ozempic or Wegovy.

We value your expertise! We're conducting a brief survey to gather insights from physicians like you on physician use and perceptions of GLP-1RA drugs for managing obesity.

Your feedback will be instrumental in helping us create content to inform physicians about this rapidly developing space.

The survey takes only 5 minutes to complete, and all responses are anonymous.

Click here to participate

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Related Videos